title: Individualisation of HIV therapy: the clinician's perspective.
abstract: Assessment of clinical and laboratory markers of HIV infection may be used to individualise antiretroviral therapy. Data suggest that measures of viral load may be of considerable value as both a baseline and dynamic therapy marker, making these tools particularly useful in driving therapeutic decisions. Similarly, in-vitro data regarding intracellular pharmacokinetics and activity, resistance patterns and potential synergy of antiretroviral agents may be used to guide selection of optimal treatment regimens in clinical practice.
authors.affiliation: Chelsea and Westminster Hospital, London.
authors.forename: B G
authors.initials: BG
authors.lastname: Gazzard
authors.forename: G J
authors.initials: GJ
authors.lastname: Moyle
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D003657:Decision Making; D015658:HIV Infections / Q000628:therapy*; D006801:Humans; D010818:Practice Patterns, Physicians'
chemical_list: D000998:Antiviral Agents